Renovaro Biosciences (RENB) Total Assets

Annual Total Assets

$163.13 M
+$104.83 M+179.81%

30 June 2024

RENB Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$121.83 M
-$41.30 M-25.32%

30 September 2024

RENB Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RENB Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+179.8%+111.7%
3 y3 years-14.0%-33.5%
5 y5 years-9.3%-31.7%

RENB Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-14.0%+179.8%-42.6%+111.7%
5 y5 years-14.0%+179.8%-42.6%+111.7%
alltimeall time-14.0%-42.6%

Renovaro Biosciences Total Assets History

DateAnnualQuarterly
Sept 2024
-
$121.83 M(-25.3%)
June 2024
$163.13 M(+179.8%)
$163.13 M(-23.2%)
Mar 2024
-
$212.28 M(+265.9%)
Dec 2023
-
$58.02 M(+0.8%)
Sept 2023
-
$57.56 M(-1.3%)
June 2023
$58.30 M(-31.1%)
-
June 2023
-
$58.30 M(-25.9%)
Mar 2023
-
$78.73 M(-1.9%)
Dec 2022
-
$80.27 M(-3.4%)
Sept 2022
-
$83.07 M(-1.8%)
June 2022
$84.63 M(-55.4%)
$84.63 M(-53.0%)
Mar 2022
-
$180.10 M(-1.7%)
Dec 2021
-
$183.14 M(-0.5%)
Sept 2021
-
$184.06 M(-2.9%)
June 2021
$189.61 M(+6.5%)
$189.61 M(+9.2%)
Mar 2021
-
$173.70 M(+0.5%)
Dec 2020
-
$172.89 M(-1.3%)
Sept 2020
-
$175.13 M(-1.7%)
June 2020
$178.10 M(-1.0%)
$178.10 M(-1.3%)
Mar 2020
-
$180.51 M(+1.2%)
Dec 2019
-
$178.36 M(-1.3%)
Sept 2019
-
$180.62 M(+0.4%)
June 2019
$179.88 M(-1.4%)
$179.88 M(+6.2%)
Mar 2019
-
$169.31 M(-2.7%)
Dec 2018
-
$173.96 M(-1.0%)
Sept 2018
-
$175.80 M(-3.7%)
June 2018
$182.50 M
$182.50 M(+26.5%)
DateAnnualQuarterly
Mar 2018
-
$144.26 M(+1743.1%)
Dec 2017
-
$7.83 M(+110.9%)
Sept 2017
-
$3.71 M(-17.9%)
June 2017
$4.52 M(+419.3%)
$4.52 M(+1082.9%)
Mar 2017
-
$382.30 K(-11.3%)
Dec 2016
-
$431.00 K(-54.4%)
Sept 2016
-
$944.70 K(+8.5%)
June 2016
$870.80 K(-58.0%)
$870.80 K(-11.2%)
Mar 2016
-
$980.50 K(-26.6%)
Dec 2015
-
$1.34 M(-22.8%)
Sept 2015
-
$1.73 M(-52.5%)
June 2015
$2.07 M(-60.4%)
-
Mar 2015
-
$3.64 M(-30.5%)
Dec 2014
$5.24 M(>+9900.0%)
$5.24 M(+105.3%)
Sept 2014
-
$2.55 M(+255.3%)
June 2014
-
$718.30 K(-21.2%)
Mar 2014
-
$911.50 K(>+9900.0%)
Dec 2013
-
$0.00(-100.0%)
Sept 2013
-
$13.20 K(-1.5%)
June 2013
-
$13.40 K(-33.0%)
Mar 2013
$20.00 K(+47.1%)
$20.00 K(+49.3%)
Dec 2012
-
$13.40 K(-13.5%)
Sept 2012
-
$15.50 K(+14.0%)
June 2012
-
$13.60 K(0.0%)
Mar 2012
$13.60 K(>+9900.0%)
$13.60 K(+2.3%)
Dec 2011
-
$13.30 K
Mar 2011
$0.00
-

FAQ

  • What is Renovaro Biosciences annual total assets?
  • What is the all time high annual total assets for Renovaro Biosciences?
  • What is Renovaro Biosciences annual total assets year-on-year change?
  • What is Renovaro Biosciences quarterly total assets?
  • What is the all time high quarterly total assets for Renovaro Biosciences?
  • What is Renovaro Biosciences quarterly total assets year-on-year change?

What is Renovaro Biosciences annual total assets?

The current annual total assets of RENB is $163.13 M

What is the all time high annual total assets for Renovaro Biosciences?

Renovaro Biosciences all-time high annual total assets is $189.61 M

What is Renovaro Biosciences annual total assets year-on-year change?

Over the past year, RENB annual total assets has changed by +$104.83 M (+179.81%)

What is Renovaro Biosciences quarterly total assets?

The current quarterly total assets of RENB is $121.83 M

What is the all time high quarterly total assets for Renovaro Biosciences?

Renovaro Biosciences all-time high quarterly total assets is $212.28 M

What is Renovaro Biosciences quarterly total assets year-on-year change?

Over the past year, RENB quarterly total assets has changed by +$64.27 M (+111.65%)